Citations (74)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
P. Prabitha, Dhivya Shanmugarajan, T. Durai Ananda Kumar & B. R. Prashantha Kumar. (2022) Multi-conformational frame from molecular dynamics as a structure-based pharmacophore model for mapping, screening and identifying ligands against PPAR-γ: a new protocol to develop promising candidates. Journal of Biomolecular Structure and Dynamics 40:6, pages 2663-2673.
Read now
Read now
Yu Kyong Kim, Jun Gi Hwang & Min Kyu Park. (2021) No Relevant Pharmacokinetic Drug–Drug Interaction Between the Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin and Lobeglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in Healthy Subjects. Drug Design, Development and Therapy 15, pages 1725-1734.
Read now
Read now
M. Ali, Assem Barakat, Ayman El-Faham, Hessa H. Al-Rasheed, Kholoud Dahlous, Abdullah Mohammed Al-Majid, Anamika Sharma, Sammer Yousuf, Mehar Sanam, Zaheer Ul-Haq, M. Iqbal Choudhary, Beatriz G. de la Torre & Fernando Albericio. (2020) Synthesis and characterisation of thiobarbituric acid enamine derivatives, and evaluation of their α-glucosidase inhibitory and anti-glycation activity. Journal of Enzyme Inhibition and Medicinal Chemistry 35:1, pages 692-701.
Read now
Read now
Laila Ahmed Eissa, Nehal Mohsen Elsherbiny & Abdalkareem Omar Maghmomeh. (2017) Effect of 2-hydroxychalcone on adiponectin level in type 2 diabetes induced experimentally in rats. Egyptian Journal of Basic and Applied Sciences 4:1, pages 1-8.
Read now
Read now
Mona H. Hetta, Asmaa I. Owis, Pierre S. Haddad & Hoda M. Eid. (2017) The fatty acid-rich fraction of Eruca sativa (rocket salad) leaf extract exerts antidiabetic effects in cultured skeletal muscle, adipocytes and liver cells. Pharmaceutical Biology 55:1, pages 810-818.
Read now
Read now
Articles from other publishers (69)
Alazne Moreno-Lanceta, Mireia Medrano-Bosch, Blanca Simón-Codina, Montserrat Barber-González, Wladimiro Jiménez & Pedro Melgar-Lesmes. (2023) PPAR-γ Agonist GW1929 Targeted to Macrophages with Dendrimer–Graphene Nanostars Reduces Liver Fibrosis and Inflammation. Pharmaceutics 15:5, pages 1452.
Crossref
Crossref
Siyi He & Gareth E. Lim. (2022) The Application of High‐Throughput Approaches in Identifying Novel Therapeutic Targets and Agents to Treat Diabetes. Advanced Biology 7:2.
Crossref
Crossref
Fangfang Liu, Yifeng Dong, Fuyu Zhong, Haodan Guo & Pengzhi Dong. (2022) CISD1 Is a Breast Cancer Prognostic Biomarker Associated with Diabetes Mellitus. Biomolecules 13:1, pages 37.
Crossref
Crossref
Makoto Noguchi, Makoto Shimizu, Peng Lu, Yu Takahashi, Yoshio Yamauchi, Shintaro Sato, Hiroshi Kiyono, Shigenobu Kishino, Jun Ogawa, Koji Nagata & Ryuichiro Sato. (2022) Lactic acid bacteria–derived γ-linolenic acid metabolites are PPARδ ligands that reduce lipid accumulation in human intestinal organoids. Journal of Biological Chemistry 298:11, pages 102534.
Crossref
Crossref
Ki Kwang Oh. (2022)
A network pharmacology study to investigate bioactive compounds and signaling pathways of garlic (
Allium sativum
L.) husk against type 2 diabetes mellitus
. Journal of Food Biochemistry 46:7.
Crossref
Crossref
Noor Fathima Anjum, Dhivya Shanmugarajan, Vasanth Kumar Shivaraju, Syed Faizan, Namburu Lalitha Naishima, B. R. Prashantha Kumar, Saleem Javid & Madhusudan N. Purohit. (2022)
Novel derivatives of eugenol as potent anti-inflammatory agents
via
PPARγ agonism: rational design, synthesis, analysis, PPARγ protein binding assay and computational studies
. RSC Advances 12:26, pages 16966-16978.
Crossref
Crossref
Celeste Carberry, Toby Turla, Lauren Koval, Hadley Hartwell, Rebecca Fry & Julia Rager. (2022) Chemical Mixtures in Household Environments: In Silico Predictions and In Vitro Testing of Potential Joint Action on PPARγ in Human Liver Cells. Toxics 10:5, pages 199.
Crossref
Crossref
Y. Xie, H. F. Berntsen, K. E. Zimmer, E. Ropstad, S. Verhaegen & L. Connolly. (2021) Lipogenic Potency of Individual Perfluorinated Alkyl Acids (PFAAs) and Persistent Organic Pollutant (POP) Mixtures at Human Blood-Based Exposure Levels on Adipogenesis in 3T3-L1 Cells. Exposure and Health 14:1, pages 87-98.
Crossref
Crossref
Lindsay M. Leonard, Mun Sun Choi & Tzu-Wen L. Cross. (2022) Maximizing the Estrogenic Potential of Soy Isoflavones through the Gut Microbiome: Implication for Cardiometabolic Health in Postmenopausal Women. Nutrients 14:3, pages 553.
Crossref
Crossref
Karima El-Sayed, Dina A. Ali, Shymaa Ahmed Maher, Dalia Ghareeb, Samy Selim, Sarah Albogami, Eman Fayad & Eman Kolieb. (2022) Prophylactic and Ameliorative Effects of PPAR-γ Agonist Pioglitazone in Improving Oxidative Stress, Germ Cell Apoptosis and Inflammation in Gentamycin-Induced Testicular Damage in Adult Male Albino Rats. Antioxidants 11:2, pages 191.
Crossref
Crossref
Shaochun Shi, Jichong Li, Xuemei Zhao, Qingbo Liu & Shao-Jiang Song. (2021) A comprehensive review: Biological activity, modification and synthetic methodologies of prenylated flavonoids. Phytochemistry 191, pages 112895.
Crossref
Crossref
Ana Chor, Maria Adriana Skeff, Christina Takiya, Raquel Gonçalves, Marcos Dias, Marcos Farina, Leonardo R. Andrade & Valeria de Mello Coelho. (2021) Emerging approaches of wound healing in experimental models of high-grade oral mucositis induced by anticancer therapy. Oncotarget 12:22, pages 2283-2299.
Crossref
Crossref
Radha Arulkumar, Hee-Jin Jung, Sang-Gyun Noh, Daeui Park & Hae-Young Chung. (2021) Cheonggukjang-Specific Component 1,3-Diphenyl-2-Propanone as a Novel PPARα/γ Dual Agonist: An In Vitro and In Silico Study. International Journal of Molecular Sciences 22:19, pages 10884.
Crossref
Crossref
Konrad A. Szychowski, Bartosz Skóra, Anna Kryshchyshyn-Dylevych, Danylo Kaminskyy, Dmytro Khyluk & Roman Lesyk. (2021) 4-thiazolidinone-based derivatives rosiglitazone and pioglitazone affect the expression of antioxidant enzymes in different human cell lines. Biomedicine & Pharmacotherapy 139, pages 111684.
Crossref
Crossref
Atsuo Tahara. (2021) Effects of SGLT2 inhibitor ipragliflozin alone and combined with pioglitazone on fluid retention in type 2 diabetic mice with NASH. European Journal of Pharmacology 901, pages 174076.
Crossref
Crossref
Jurga Bernatoniene, Jurga Andreja Kazlauskaite & Dalia Marija Kopustinskiene. (2021) Pleiotropic Effects of Isoflavones in Inflammation and Chronic Degenerative Diseases. International Journal of Molecular Sciences 22:11, pages 5656.
Crossref
Crossref
Fatemeh Amin, Arghavan Memarzia, Ali Roohbakhsh, Farzaneh Shakeri & Mohammad Hossein Boskabady. (2021) Zataria multiflora and Pioglitazone Affect Systemic Inflammation and Oxidative Stress Induced by Inhaled Paraquat in Rats. Mediators of Inflammation 2021, pages 1-11.
Crossref
Crossref
Amada Pasha, Maura Calvani & Claudio Favre. (2021) β3-Adrenoreceptors as ROS Balancer in Hematopoietic Stem Cell Transplantation. International Journal of Molecular Sciences 22:6, pages 2835.
Crossref
Crossref
Ramandeep Kaur, Rajnish Kumar, Nilambra Dogra, Ashok Kumar, Ashok Kumar Yadav & Manoj Kumar. (2021) Synthesis and studies of thiazolidinedione–isatin hybrids as α-glucosidase inhibitors for management of diabetes. Future Medicinal Chemistry 13:5, pages 457-485.
Crossref
Crossref
Mallikarjuna B. G.Uma V. Manjappara. (2021) Obestatin and Rosiglitazone Differentially Modulate Lipid Metabolism Through Peroxisome Proliferator-activated Receptor-γ (PPARγ) in Pre-adipose and Mature 3T3-L1 Cells. Cell Biochemistry and Biophysics 79:1, pages 73-85.
Crossref
Crossref
Serena Stopponi, Yannick Fotio, Carlo Cifani, Hongwu Li, Carolina L Haass-Koffler, Nazzareno Cannella, Gregory Demopulos, George Gaitanaris & Roberto Ciccocioppo. (2021)
Andrographis paniculata
and Its Main Bioactive Ingredient Andrographolide Decrease Alcohol Drinking and Seeking in Rats Through Activation of Nuclear PPARγ Pathway
. Alcohol and Alcoholism 56:2, pages 240-249.
Crossref
Crossref
Alina Kuryłowicz. (2020) The Role of Isoflavones in Type 2 Diabetes Prevention and Treatment—A Narrative Review. International Journal of Molecular Sciences 22:1, pages 218.
Crossref
Crossref
Niki Katsiki & Ele Ferrannini. (2020) Anti-inflammatory properties of antidiabetic drugs: A “promised land” in the COVID-19 era?. Journal of Diabetes and its Complications 34:12, pages 107723.
Crossref
Crossref
B. G. Mallikarjuna & Uma V. Manjappara. (2020) Co-administration with Obestatin Reduces Accumulation of Subcutaneous Fat Due to Rosiglitazone Administration in DIO-C57BL/6 Mice. International Journal of Peptide Research and Therapeutics 26:4, pages 2307-2315.
Crossref
Crossref
Hilda Loza-Rodríguez, Samuel Estrada-Soto, Francisco J. Alarcón-Aguilar, Fengyang Huang, Guillermo Aquino-Jarquín, Ángeles Fortis-Barrera, Abraham Giacoman-Martínez & Julio C. Almanza-Pérez. (2020) Oleanolic acid induces a dual agonist action on PPARγ/α and GLUT4 translocation: A pentacyclic triterpene for dyslipidemia and type 2 diabetes. European Journal of Pharmacology 883, pages 173252.
Crossref
Crossref
Jayanta Dowarah & Ved Prakash Singh. (2020) Anti-diabetic drugs recent approaches and advancements. Bioorganic & Medicinal Chemistry 28:5, pages 115263.
Crossref
Crossref
Alina Kuryłowicz, Marta Cąkała-Jakimowicz & Monika Puzianowska-Kuźnicka. (2020) Targeting Abdominal Obesity and Its Complications with Dietary Phytoestrogens. Nutrients 12:2, pages 582.
Crossref
Crossref
Vasilios G. Athyros, Stergios A. Polyzos, Jiannis Kountouras, Niki Katsiki, Panagiotis Anagnostis, Michael Doumas & Christos S. Mantzoros. (2020) Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block. Current Vascular Pharmacology 18:2, pages 172-181.
Crossref
Crossref
Ágnes Németh, Miklós M. Mózes, Laurent Calvier, Georg Hansmann & Gábor Kökény. (2019) The PPARγ agonist pioglitazone prevents TGF-β induced renal fibrosis by repressing EGR-1 and STAT3. BMC Nephrology 20:1.
Crossref
Crossref
Atsuo Tahara & Toshiyuki Takasu. (2019) SGLT2 inhibitor ipragliflozin alone and combined with pioglitazone prevents progression of nonalcoholic steatohepatitis in a type 2 diabetes rodent model. Physiological Reports 7:22.
Crossref
Crossref
Waquar Ahsan. (2019) The Journey of Thiazolidinediones as Modulators of PPARs for the Management of Diabetes: A Current Perspective. Current Pharmaceutical Design 25:23, pages 2540-2554.
Crossref
Crossref
Manoj Dhameja & Preeti Gupta. (2019) Synthetic heterocyclic candidates as promising α-glucosidase inhibitors: An overview. European Journal of Medicinal Chemistry 176, pages 343-377.
Crossref
Crossref
Geetanjali Ganguli, Utsav Mukherjee & Avinash Sonawane. (2019) Peroxisomes and Oxidative Stress: Their Implications in the Modulation of Cellular Immunity During Mycobacterial Infection. Frontiers in Microbiology 10.
Crossref
Crossref
Simran Kaur, Alo Nag, Gurudutta Gangenahalli & Kulbhushan Sharma. (2019) Peroxisome Proliferator Activated Receptor Gamma Sensitizes Non-small Cell Lung Carcinoma to Gamma Irradiation Induced Apoptosis. Frontiers in Genetics 10.
Crossref
Crossref
Sara Freitas, Natália Gonçalves Silva, Maria Lígia Sousa, Tiago Ribeiro, Filipa Rosa, Pedro N. Leão, Vitor Vasconcelos, Mariana Alves Reis & Ralph Urbatzka. (2019) Chlorophyll Derivatives from Marine Cyanobacteria with Lipid-Reducing Activities. Marine Drugs 17:4, pages 229.
Crossref
Crossref
Hannah E. Wilson, Kacey K. Rhodes, Daniel Rodriguez, Ikttesh Chahal, David A. Stanton, Joseph Bohlen, Mary Davis, Aniello M. Infante, Hannah Hazard-Jenkins, David J. Klinke, Elena N. Pugacheva & Emidio E. Pistilli. (2019) Human Breast Cancer Xenograft Model Implicates Peroxisome Proliferator–activated Receptor Signaling as Driver of Cancer-induced Muscle Fatigue. Clinical Cancer Research 25:7, pages 2336-2347.
Crossref
Crossref
Jing Liu, Yeu-Ching Shi & David Yue-Wei Lee. (2019) Applications of Pueraria lobata in treating diabetics and reducing alcohol drinking. Chinese Herbal Medicines 11:2, pages 141-149.
Crossref
Crossref
Julie M. Hall, Heather R. Powell, Lara Rajic & Kenneth S. Korach. (2019)
The Role of Dietary Phytoestrogens and the Nuclear Receptor PPARγ in Adipogenesis: An
in Vitro
Study
. Environmental Health Perspectives 127:3.
Crossref
Crossref
Sujith Rajan, Ganesh Panzade, Ankita Srivastava, Kripa Shankar, Rajesh Pandey, Durgesh Kumar, Sanchita Gupta, Abhishek Gupta, Salil Varshney, Muheeb Beg, Raj Kumar Mishra, Ravi Shankar & Anil Gaikwad. (2018) miR-876-3p regulates glucose homeostasis and insulin sensitivity by targeting adiponectin. Journal of Endocrinology 239:1, pages 1-17.
Crossref
Crossref
Valentina Rodriguez, Jonathan D. Newman & Arthur Z. Schwartzbard. (2018) Towards more specific treatment for diabetic dyslipidemia. Current Opinion in Lipidology 29:4, pages 307-312.
Crossref
Crossref
Lima Lawrence, Venu Menon & Sangeeta Kashyap. (2018) Cardiovascular and Renal Outcomes of Newer Anti-Diabetic Medications in High-Risk Patients. Current Cardiology Reports 20:8.
Crossref
Crossref
Tarik Hadi, Romain Douhard, Alexandre M.M. Dias, Maeva Wendremaire, Maria Pezzè, Marc Bardou, Paul Sagot, Carmen Garrido & Frédéric Lirussi. (2017) Beta3 adrenergic receptor stimulation in human macrophages inhibits NADPHoxidase activity and induces catalase expression via PPARγ activation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1864:10, pages 1769-1784.
Crossref
Crossref
SM Sheikh Ghadzi, MO Karlsson & MC Kjellsson. (2017) Implications for Drug Characterization in Glucose Tolerance Tests Without Insulin: Simulation Study of Power and Predictions Using Model-Based Analysis. CPT: Pharmacometrics & Systems Pharmacology 6:10, pages 686-694.
Crossref
Crossref
Yu Takahashi, Shintaro Sato, Yosuke Kurashima, Chen-Yi Lai, Makoto Otsu, Mikio Hayashi, Takayuki Yamaguchi & Hiroshi Kiyono. (2017) Reciprocal Inflammatory Signaling Between Intestinal Epithelial Cells and Adipocytes in the Absence of Immune Cells. EBioMedicine 23, pages 34-45.
Crossref
Crossref
Maria Eliza de Castro Moreira, Dorina Isabel Gomes Natal, Renata Celi Lopes Toledo, Natalia Medina Ramirez, Sonia Machado Rocha Ribeiro, Laércio dos Anjos Benjamin, Leandro Licursi de Oliveira, Dayana Alves Rodrigues, Jacinto Demuner Antônio, Marcia Paranho Veloso, Marcelo Henrique Dos Santos & Hercia Stampini Duarte Martino. (2017) Bacupari peel extracts ( Garcinia brasiliensis ) reduce high-fat diet-induced obesity in rats. Journal of Functional Foods 29, pages 143-153.
Crossref
Crossref
Olubanke O. Ogunlana, Oluseyi E. Ogunlana, Stanley K. Ugochukwu & Efejiro Ashano. (2016) Evaluation of Biochemical Toxicity and Antioxidant Properties
of Pioglitazone on Albino Wistar Rats. Journal of Medical Sciences 17:1, pages 10-16.
Crossref
Crossref
Thubasni Kunasegaran, Mohd Rais Mustafa, Dharmani Devi Murugan & Francis I. Achike. (2016) The bioflavonoid quercetin synergises with PPAR-γ agonist pioglitazone in reducing angiotensin-II contractile effect in fructose-streptozotocin induced diabetic rats. Biochimie 125, pages 131-139.
Crossref
Crossref
Nagaraj M. Kulkarni, Sandeep Malampati, Mahamad Yunnus A. Mahat, S. Chandrasekaran, J. Raghul, Ansar Ali Khan, Uma Maheswari Krishnan & Shridhar Narayanan. (2016) Altered pharmacokinetics of rosiglitazone in a mouse model of non-alcoholic fatty liver disease. Drug Metabolism and Personalized Therapy 31:3.
Crossref
Crossref
Saikat Sen, Raja Chakraborty & Biplab DeSaikat Sen, Raja Chakraborty & Biplab De. 2016. Diabetes Mellitus in 21st Century. Diabetes Mellitus in 21st Century
153
174
.
Cai-Xia Chen, Li-Chao Yang, Xu-Dong Xu, Xiao Wei, Ya-Ting Gai, Lu Peng, Han Guo, Hao-Zhou, Yi-Qing Wang & Xin Jin. (2015) Effect of propane-2-sulfonic acid octadec-9-enyl-amide on the expression of adhesion molecules in human umbilical vein endothelial cells. European Journal of Pharmacology 756, pages 15-21.
Crossref
Crossref
Sawsan A. Zaitone, Bassant M. Barakat, Shymaa E. Bilasy, Manal S. Fawzy, Eman Z. Abdelaziz & Noha E. Farag. (2015) Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure. Naunyn-Schmiedeberg's Archives of Pharmacology 388:6, pages 587-600.
Crossref
Crossref
Christina Kopp, Afshin Hosseini, Shiva Singh, Petra Regenhard, Hamed Khalilvandi-Behroozyar, Helga Sauerwein & Manfred Mielenz. (2014) Nicotinic Acid Increases Adiponectin Secretion from Differentiated Bovine Preadipocytes through G-Protein Coupled Receptor Signaling. International Journal of Molecular Sciences 15:11, pages 21401-21418.
Crossref
Crossref
Manjinder Singh, Maninder Kaur & Om Silakari. (2014) Flavones: An important scaffold for medicinal chemistry. European Journal of Medicinal Chemistry 84, pages 206-239.
Crossref
Crossref
L. S. Litvinova, E. V. Kirienkova, I. O. Mazunin, M. A. Vasilenko & N. S. Fattakhov. (2014) Pathogenesis of insulin resistance in metabolic obesity. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry 8:3, pages 192-202.
Crossref
Crossref
Christina Kopp, Shiva Singh, Petra Regenhard, Ute Müller, Helga Sauerwein & Manfred Mielenz. (2014) Trans-Cinnamic Acid Increases Adiponectin and the Phosphorylation of AMP-Activated Protein Kinase through G-Protein-Coupled Receptor Signaling in 3T3-L1 Adipocytes. International Journal of Molecular Sciences 15:2, pages 2906-2915.
Crossref
Crossref
Bing-Xin Xiao, Qian Wang, Li-Qing Fan, Ling-Ti Kong, Shu-Ren Guo & Qi Chang. (2014) Pharmacokinetic mechanism of enhancement by Radix Pueraria flavonoids on the hyperglycemic effects of Cortex Mori extract in rats. Journal of Ethnopharmacology 151:2, pages 846-851.
Crossref
Crossref
Azadeh Matin, Munikumar Reddy Doddareddy, Navnath Gavande, Srinivas Nammi, Paul W. Groundwater, Rebecca H. Roubin & David E. Hibbs. (2013) The discovery of novel isoflavone pan peroxisome proliferator-activated receptor agonists. Bioorganic & Medicinal Chemistry 21:3, pages 766-778.
Crossref
Crossref
Vincent Marion, Anaïs Mockel, Charlie De Melo, Cathy Obringer, Aurélie Claussmann, Alban Simon, Nadia Messaddeq, Myriam Durand, Luc Dupuis, Jean-Philippe Loeffler, Peter King, Catherine Mutter-Schmidt, Nikolai Petrovsky, Corinne Stoetzel & Hélène Dollfus. (2012) BBS-Induced Ciliary Defect Enhances Adipogenesis, Causing Paradoxical Higher-Insulin Sensitivity, Glucose Usage, and Decreased Inflammatory Response. Cell Metabolism 16:3, pages 363-377.
Crossref
Crossref
Alok K. Verma, Himanshu Singh, Mavurapu Satyanarayana, Swayam P. Srivastava, Priti Tiwari, Amar B. Singh, Anil K. Dwivedi, Shio K. Singh, Mukesh Srivastava, Chandishwar Nath, Ram Raghubir, Arvind K. Srivastava & Ram Pratap. (2012) Flavone-Based Novel Antidiabetic and Antidyslipidemic Agents. Journal of Medicinal Chemistry 55:10, pages 4551-4567.
Crossref
Crossref
Amanda Bernardes, Fernanda A. H. Batista, Mario de Oliveira Neto, Ana Carolina M. Figueira, Paul Webb, Daniel Saidemberg, Mario S. Palma & Igor Polikarpov. (2012) Low-Resolution Molecular Models Reveal the Oligomeric State of the PPAR and the Conformational Organization of Its Domains in Solution. PLoS ONE 7:2, pages e31852.
Crossref
Crossref
J. Pita, A. Panadero, L. Soriano-Guillén, E. Rodríguez & A. Rovira. (2012) The insulin sensitizing effects of PPAR-γ agonist are associated to changes in adiponectin index and adiponectin receptors in Zucker fatty rats. Regulatory Peptides 174:1-3, pages 18-25.
Crossref
Crossref
Philipp M. Toth, Simone Naruhn, Veronika F. S. Pape, Stefanie M. A. Dörr, Gerhard Klebe, Rolf Müller & Wibke E. Diederich. (2012) Development of Improved PPARβ/δ Inhibitors. ChemMedChem 7:1, pages 159-170.
Crossref
Crossref
Ka H. Wong, George Q. Li, Kong M. Li, Valentina Razmovski-Naumovski & Kelvin Chan. (2011) Kudzu root: Traditional uses and potential medicinal benefits in diabetes and cardiovascular diseases. Journal of Ethnopharmacology 134:3, pages 584-607.
Crossref
Crossref
Jennifer E. Foreman, Arun K. Sharma, Shantu Amin, Frank J. Gonzalez & Jeffrey M. Peters. (2010) Ligand activation of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) inhibits cell growth in a mouse mammary gland cancer cell line. Cancer Letters 288:2, pages 219-225.
Crossref
Crossref
LUCIA KNOPFOVÁ & JAN ŠMARDA. (2010) The use of Cox-2 and PPARγ signaling in anti-cancer therapies. Experimental and Therapeutic Medicine 1:2, pages 257-264.
Crossref
Crossref
Rüdiger Hardeland. (2009) Neuroprotection by Radical Avoidance: Search for Suitable Agents. Molecules 14:12, pages 5054-5102.
Crossref
Crossref
Azadeh Matin, Navnath Gavande, Moon S. Kim, Nancy X. Yang, Noeris K. Salam, Jane R. Hanrahan, Rebecca H. Roubin & David E. Hibbs. (2009) 7-Hydroxy-benzopyran-4-one Derivatives: A Novel Pharmacophore of Peroxisome Proliferator-Activated Receptor α and -γ (PPARα and γ) Dual Agonists. Journal of Medicinal Chemistry 52:21, pages 6835-6850.
Crossref
Crossref
B. S. Muhlhausler, J. L. Morrison & I. C. McMillen. (2009) Rosiglitazone Increases the Expression of Peroxisome Proliferator-Activated Receptor-γ Target Genes in Adipose Tissue, Liver, and Skeletal Muscle in the Sheep Fetus in Late Gestation. Endocrinology 150:9, pages 4287-4294.
Crossref
Crossref
Irene A. Weiss, Guy Valiquette & Monica D. Schwarcz. (2009) Impact of Glycemic Treatment Choices on Cardiovascular Complications in Type 2 Diabetes. Cardiology in Review 17:4, pages 165-175.
Crossref
Crossref